In conclusion, the present study demonstrated that paeoniflorin reversed fructose-induced insulin resistance and hepatic steatosis, suggesting the mechanism might be involved in the activation of LKB1/AMPK and insulin signaling, which resulted in the inhibition of lipogenesis and the activation of β-oxidation and glycogenesis. This evidence concerns the gene INS and fatty liver disease.